These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25641892)

  • 1. Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.
    Tappeiner C; Miserocchi E; Bodaghi B; Kotaniemi K; Mackensen F; Gerloni V; Quartier P; Lutz T; Heiligenhaus A
    J Rheumatol; 2015 Apr; 42(4):706-11. PubMed ID: 25641892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    Birolo C; Zannin ME; Arsenyeva S; Cimaz R; Miserocchi E; Dubko M; Deslandre CJ; Falcini F; Alessio M; La Torre F; Denisova E; Martini G; Nikishina I; Zulian F
    J Rheumatol; 2016 Nov; 43(11):2068-2073. PubMed ID: 27633826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).
    Heiligenhaus A; Miserocchi E; Heinz C; Gerloni V; Kotaniemi K
    Rheumatology (Oxford); 2011 Aug; 50(8):1390-4. PubMed ID: 21378109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
    Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
    Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
    Miserocchi E; Modorati G; Berchicci L; Pontikaki I; Meroni P; Gerloni V
    Br J Ophthalmol; 2016 Jun; 100(6):782-6. PubMed ID: 26396026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile idiopathic arthritis-associated uveitis.
    Sen ES; Ramanan AV
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):517-534. PubMed ID: 29773271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
    Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
    J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
    Cecchin V; Zannin ME; Ferrari D; Pontikaki I; Miserocchi E; Paroli MP; Bracaglia C; Marafon DP; Pastore S; Parentin F; Simonini G; De Libero C; Falcini F; Petaccia A; Filocamo G; De Marco R; La Torre F; Guerriero S; Martino S; Comacchio F; Muratore V; Martini G; Vittadello F; Zulian F
    J Rheumatol; 2018 Aug; 45(8):1167-1172. PubMed ID: 29657140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis.
    Kenawy N; Cleary G; Mewar D; Beare N; Chandna A; Pearce I
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):297-300. PubMed ID: 20922440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis.
    Grajewski RS; Zurek-Imhoff B; Roesel M; Heinz C; Heiligenhaus A
    Acta Ophthalmol; 2012 Nov; 90(7):657-62. PubMed ID: 21310018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series.
    La Torre F; Cattalini M; Teruzzi B; Meini A; Moramarco F; Iannone F
    BMC Res Notes; 2014 May; 7():316. PubMed ID: 24886032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing juvenile idiopathic arthritis-associated uveitis.
    Hawkins MJ; Dick AD; Lee RJ; Ramanan AV; Carreño E; Guly CM; Ross AH
    Surv Ophthalmol; 2016; 61(2):197-210. PubMed ID: 26599495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).
    Foeldvari I; Klotsche J; Simonini G; Edelsten C; Angeles-Han ST; Bangsgaard R; de Boer J; Brumm G; Torrent RB; Constantin T; DeLibero C; Diaz J; Gerloni VM; Guedes M; Heiligenhaus A; Kotaniemi K; Leinonen S; Minden K; Miranda V; Miserocchi E; Nielsen S; Niewerth M; Pontikaki I; de Vicuna CG; Zilhao C; Yeh S; Anton J
    Pediatr Rheumatol Online J; 2019 Oct; 17(1):66. PubMed ID: 31575380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis in juvenile idiopathic arthritis: recent therapeutic advances.
    Wells JM; Smith JR
    Ophthalmic Res; 2015; 54(3):124-7. PubMed ID: 26315291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
    Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-Pérez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalhães C; Sztajnbok F; Goldenstein-Schainberg C; Scheinberg M; Penades IC; Fischbach M; Orozco J; Hashkes PJ; Hom C; Jung L; Lepore L; Oliveira S; Wallace CA; Sigal LH; Block AJ; Covucci A; Martini A; Giannini EH; ;
    Lancet; 2008 Aug; 372(9636):383-91. PubMed ID: 18632147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and outcome of uveitis in children.
    Friling R; Kramer M; Snir M; Axer-Siegel R; Weinberger D; Mukamel M
    J AAPOS; 2005 Aug; 9(4):379-82. PubMed ID: 16102490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review.
    Kolomeyer AM; Crane ES; Tu Y; Liu D; Chu DS
    Can J Ophthalmol; 2017 Oct; 52(5):458-462. PubMed ID: 28985804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.
    Marrani E; Paganelli V; de Libero C; Cimaz R; Simonini G
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1813-6. PubMed ID: 26311261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.